Stibbe advises ING

Experience - Stibbe advises Firmenich, the world’s largest privately-owned fragrance and taste company, on its merger with Royal DSM, to establish the leading creation and innovation partner in nutrition, beauty and well-being (DSM-Firmenich). DSM-Firmenich will be listed on Euronext Amsterdam. 

Experience - Stibbe advises FL Entertainment, a global leader in independent content production and fastest-growing online sports betting platform in Europe through its Banijay Group and Betclic Everest Group businesses, on its business combination with Pegasus Entrepreneurial Acquisition Company Europe B.V. (Pegasus Entrepreneurs), a SPAC listed on Euronext Amsterdam, pursuant to which FL Entertainment will become a public company with an initial enterprise value of €7.2 billion  – the largest business combination by a European-listed SPAC.

Experience - On 22 April 2022, Amsterdam Trade Bank N.V. ("ATB") filed for bankruptcy and was declared bankrupt by the Amsterdam District Court. The court appointed A. van Hees and J.E.P.A. van Hooff as bankruptcy trustees.

Experience - Stibbe advises Azerion, a high-growth, profitable, digital entertainment and media company, on its business combination with European FinTech IPO Company 1 B.V. (EFIC1), a SPAC listed on Euronext Amsterdam, pursuant to which Azerion will become a public company with an initial enterprise value of €1.3 billion.

Experience - Stibbe advises Odyssey Acquisition on its EUR 1.5 billion business combination With BenevolentAI. The combination of Odyssey Acquisition S.A. (Odyssey), a Euronext Amsterdam-listed special-purpose acquisition company (SPAC) focused on European healthcare and TMT growth companies, and BenevolentAI, a leading clinical-stage AI drug discovery company, represents the largest European SPAC merger announced to date and one of the largest Euronext Amsterdam biotech listings ever.

Experience - Stibbe advises Brigade-M3 European Acquisition Corp. on its IPO on Euronext Amsterdam. Brigade-M3 European Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) that was incorporated for purposes of effecting a business combination with a company with significant operations in Europe which has positively benefited from a structural shift caused by the COVID-19 pandemic or has been negatively impacted by a temporary dislocation caused by the COVID-19 pandemic. The SPAC will have 18 months from 14 December 2021 to complete a Business Combination.